WESTCHESTER, Ill., Nov. 7, 2026 (GLOBE NEWSWIRE) — Ingredion Incorporated (NYSE: INGR), a global provider of ingredient solutions for the food and beverage industry, reported its financial results for the third quarter of 2026.

The company said its Texture & Health segment recorded higher net sales for the 10th consecutive quarter and gained market share in strategic areas, supported in particular by continued global growth in clean-label products. However, third-quarter operating income declined 19% year over year on both a reported and adjusted basis.

Reported diluted earnings per share were $2.23 for the third quarter of 2026, compared with $2.61 in the third quarter of 2025. Adjusted diluted earnings per share were $2.28, compared with $2.75 a year earlier.

Ingredion revised its full-year guidance to a range of $8.04 to $8.49 for reported diluted earnings per share and $9.25 to $9.70 for adjusted diluted earnings per share.

“Our third-quarter results are below our expectations, primarily due to a slower-than-expected financial recovery at our Argo facility, as well as pressures from higher input costs and slower consumption,” Jim Zallie, Ingredion’s chairman and chief executive officer, said.

“Although production at the Argo facility remained stable for the second consecutive quarter and inventories were largely replenished, high manufacturing costs and slower demand in the food and beverage industry constrained our outlook for profitable sales growth. Our now more reliable facilities allow us to focus on sustainably reducing operating costs and increasing sales volumes. While we expect these actions to improve results, the recovery is slower than anticipated,” Zallie said.

“Within Texture & Health, net sales growth was again a bright spot this quarter. Sales increased for the 10th consecutive quarter, supported by sustained global demand for clean-label solutions as customers increasingly favor simpler formulations, affordability and improved nutritional value. Profit growth in this segment was nevertheless constrained by higher tapioca costs and inflation in manufacturing input costs,” he said.

Zallie added that the Food and Industrial Ingredients–LATAM segment benefited from rising brewing and beverage volumes in Mexico and Brazil. Those gains were offset by foreign-exchange effects associated with the strength of the Mexican peso and by the impact of the earthquake that struck Colombia in August on the company’s Andean operations.

“In light of these results, we are lowering our full-year outlook, particularly to reflect the slower recovery in the Food and Industrial Ingredients–U.S./Canada business, as well as the effects of higher input costs and slower demand,” Zallie said.

“To prepare for the future, we are taking steps to improve our financial results through disciplined management of operating costs and expenses, while continuing to invest in our specialized growth platforms. As we continue preparing for the integration of Tate & Lyle as part of its planned acquisition, we are laying the foundation for an even stronger company with more opportunities for growth, innovation and shareholder value creation in 2027 and beyond,” he said.

The Tate & Lyle acquisition remains pending. Under the company’s disclosures, completion is subject to antitrust and other conditions, and Ingredion recorded $59 million in pretax acquisition and integration costs during the first nine months of 2026, primarily related to the proposed combination.

Reported results are prepared in accordance with accounting principles generally accepted in the United States, or GAAP. Adjusted financial measures are non-GAAP measures. Ingredion said a reconciliation of the non-GAAP measures to the most directly comparable GAAP measures is provided in Section II, “Non-GAAP Information,” in the supplemental financial information following the consolidated financial statement summary.

Third-quarter financial performance

Ingredion’s third-quarter net sales declined 1%, primarily because of the divestiture of its majority interest in its Pakistan business. Excluding Pakistan, net sales increased 2%, supported by favorable foreign-exchange effects and higher volumes in the Food and Industrial Ingredients–LATAM and Texture & Health segments.

Reported operating income was $201 million, while adjusted operating income was $206 million. The $5 million difference between reported and adjusted operating income reflected acquisition-related costs, impairment charges and expenses associated with the Argo thermal incident, largely offset by a net restructuring gain. Excluding foreign-exchange effects, both reported and adjusted operating income declined 21% year over year.

Texture & Health

Third-quarter operating income for Texture & Health was $95 million, down $10 million from the prior-year quarter. The decline resulted from higher tapioca and manufacturing costs and unfavorable price-mix effects, partly offset by favorable volume and operating-expense effects. Excluding foreign-exchange effects, segment operating income declined 9%.

The segment’s net sales increased for the 10th consecutive quarter. Ingredion attributed the performance to continued global demand for clean-label solutions and gains in strategic markets. The company said customers are increasingly seeking simpler formulations, affordable products and improved nutritional value.

Food and Industrial Ingredients–LATAM

Third-quarter operating income for Food and Industrial Ingredients–LATAM was $109 million, down $7 million from the prior-year period. The decline primarily reflected transactional foreign-exchange effects in Mexico and business disruption associated with the earthquake in Colombia, partly offset by higher sales. Excluding foreign-exchange effects, segment operating income declined 10%.

The segment benefited from higher brewing and beverage volumes in Mexico and Brazil. The benefit was counterbalanced by the continued strength of the Mexican peso and the impact of the August earthquake on operations in the Andean region.

Food and Industrial Ingredients–U.S./Canada

Third-quarter operating income for Food and Industrial Ingredients–U.S./Canada was $52 million, down $29 million from the previous year. The decline was driven by higher manufacturing costs at the Argo plant and lower volumes, partly offset by favorable price effects. Excluding foreign-exchange effects, operating income declined 36%.

According to the company’s reconciliation notes, the Argo thermal incident generated $25 million in pretax charges during the first nine months of 2026, following $2 million of pretax costs in the same period of 2025, underscoring why the facility’s cost recovery is central to the segment’s outlook.

Other businesses

The operating loss attributable to Other Businesses increased by $7 million from the prior-year quarter. The change reflected the impact of the divestiture of the company’s majority interest in its Pakistan business, partly offset by continued improvement in the Protein Fortification business.

“Other Businesses” refers to activities from several operating segments that are not individually or collectively classified as reportable segments. Net sales in this category primarily consist of sales of stevia and other ingredients generated through Ingredion’s PureCircle activities, other sugar-reduction activities, and pea-protein ingredients sold through the Protein Fortification business.

Financial position and other financial items

As of Sept. 30, 2026, total debt was $1.8 billion and cash, including short-term investments, was $993 million. At Dec. 31, 2025, total debt was $1.8 billion and cash, including short-term investments, was $1.0 billion.

Reported net financing costs were $10 million in the third quarter of 2026, compared with $7 million in the same period a year earlier.

The reported and adjusted effective tax rates for the third quarter were 26.8% and 26.4%, respectively, compared with 28.6% and 26.4% in the prior-year quarter. The lower reported effective tax rate primarily reflected a change in the permanent-reinvestment status of the company’s Pakistan operations, recorded in the same period of the prior year, and a favorable decision in Brazil regarding the taxation of ICMS credits. These favorable effects were partly offset by the change in the value of the Mexican peso against the U.S. dollar.

Capital expenditures totaled $313 million during the first nine months of 2026, partly offset by $36 million in proceeds from the sale of certain real estate assets.

Dividends and share repurchases

Ingredion paid shareholders a total of $53 million in dividends during the third quarter. On Sept. 17, 2026, the company announced a quarterly dividend of $0.83 per share, paid on Oct. 20, 2026. The increase represented the company’s 12th consecutive annual dividend increase.

As of Sept. 30, the company had repurchased $85 million of its common stock and maintained its objective of repurchasing $100 million of shares during the full year.

Revised 2026 outlook

For full-year 2026, Ingredion expects reported diluted earnings per share of $8.04 to $8.49 and adjusted diluted earnings per share of $9.25 to $9.70.

The company continues to expect full-year 2026 net sales to remain stable. The outlook reflects higher volumes and favorable foreign-exchange effects, partly offset by unfavorable price-mix effects and the previously announced divestiture of its majority interest in its Pakistan operations. Excluding Pakistan, net sales are expected to remain stable or grow at a modest single-digit rate.

Reported full-year operating income is expected to decline by a double-digit percentage. Adjusted operating income is expected to decrease by approximately 15%, primarily because of operating challenges in Food and Industrial Ingredients–U.S./Canada.

Ingredion’s segment assumptions for 2026 include the following:

• Texture & Health operating income is expected to remain stable or increase by a modest single-digit percentage. Sales-volume growth is expected to support the segment, partly offset by higher-than-expected inflation in input costs.

• Food and Industrial Ingredients–LATAM operating income is expected to decline by 5% to 10%, reflecting the continued strength of the Mexican peso.

• Food and Industrial Ingredients–U.S./Canada operating income is now expected to decline by 35% to 40%, due to elevated operating costs at the Argo facility.

• The operating loss for Other Businesses is expected to be approximately $15 million, reflecting the exclusion of the Pakistan business’s contribution to earnings during the second half of the year.

General and administrative expenses are expected to decline by approximately 5% for full-year 2026.

Ingredion expects a full-year reported effective tax rate of 27.9% to 28.9% and an adjusted effective tax rate of 26.5% to 27.5%.

Cash flow from operating activities is now expected to range from $650 million to $750 million. Full-year capital expenditures are expected to be between $450 million and $490 million.

The outlook reflects tariffs in effect in October 2026. It excludes acquisition-related integration and restructuring costs and any potential impairment charges.

Against these revised assumptions, developments to track in coming quarters include progress on operating-cost reduction at the Argo facility, performance of each segment against the updated guidance ranges, and milestones in the pending Tate & Lyle acquisition.

Conference call and webcast

Ingredion is scheduled to hold a conference call on Thursday, Nov. 5, 2026, at 8 a.m. Central time, or 9 a.m. Eastern time. The call is to be jointly hosted by Jim Zallie, chairman and chief executive officer, and Diego Reynoso, executive vice president and chief financial officer.

The conference call is scheduled to be webcast live at A presentation containing additional financial and operating information was made available for download on the company’s website several hours before the call. A replay is to be available for a limited time at

About Ingredion

Ingredion Incorporated (NYSE: INGR), headquartered in the Chicago suburbs, is a global provider of ingredient solutions serving customers in more than 120 countries. With annual net sales of nearly $7.2 billion in 2025, the company transforms grains, fruits, vegetables and other plant-based materials into value-added ingredient solutions for the food, beverage, animal nutrition, brewing and industrial markets.

Through its Idea Labs innovation centers around the world and with the support of approximately 11,000 employees, Ingredion works with customers to develop ingredient solutions that combine the potential of people, nature and technology to make life better. More information and the latest company news are available at ingredion.com.

Forward-looking statements

This release contains or may contain forward-looking statements within the meaning of Section 27A of the U.S. Securities Act of 1933, as amended, and Section 21E of the U.S. Securities Exchange Act of 1934, as amended. Ingredion intends for these forward-looking statements to be covered by the safe-harbor provisions for forward-looking statements under U.S. federal law.

Forward-looking statements include, among other things, statements concerning expectations for full-year 2026 reported and adjusted earnings per share, net sales, reported and adjusted operating income, general and administrative expenses, reported and adjusted effective tax rates, cash flow from operating activities and capital expenditures. They also include other statements about future prospects and operations, financial condition, volumes, cash flows, expenses or other financial items, including plans, strategies and objectives developed by management in connection with those matters and any related underlying assumptions, expectations or beliefs.

The statements also include expectations regarding the completion and benefits of the pending acquisition of Tate & Lyle, including statements concerning plans, objectives, intentions and expectations regarding the future operations and financial performance of the combined group.

Forward-looking statements are sometimes identified by the use of forward-looking terminology. Words and phrases such as “may,” “will,” “should,” “anticipates,” “assumes,” “believes,” “expects,” “plans,” “intends,” “continues,” “pro forma,” “forecast,” “outlook,” “opportunities” and “potential,” as well as similar expressions or their negative forms, constitute forward-looking statements. Any statement other than a statement of historical fact may also be a forward-looking statement.

Forward-looking statements reflect current circumstances or expectations and are subject to numerous inherent risks and uncertainties, most of which are difficult to predict and beyond the company’s control. Although Ingredion believes the expectations expressed in its forward-looking statements are based on reasonable assumptions, there can be no assurance that the company’s forecasts will prove accurate.

Risks related to the pending acquisition include, among others, the possibility that the transaction will not be completed on the expected timetable or at all because essential antitrust or other conditions cannot be satisfied, or for other reasons; the risk that the anticipated benefits of the transaction will not be fully realized or will take longer than expected, including because of the risks and uncertainties described below; the inability to integrate Ingredion’s and Tate & Lyle’s businesses effectively or manage the combined group’s expanded operations; the incurrence of substantial expenses and debt by Ingredion and the combined group to complete the acquisition and operate the business after completion; and the risk that Tate & Lyle could lose contracts, customers, distributors, suppliers, vendors or other business partners as a result of the pending acquisition.

Actual results and developments could differ materially from those expressed or implied in the forward-looking statements because of various risks and uncertainties, including changes in consumer habits, preferences, behavior, perceptions, price sensitivity and demand; the effects of geopolitical developments, tensions, threats or conflicts on the availability and prices of raw materials and energy, supply chains, foreign-exchange rates and interest rates; the effects of global economic and business conditions on demand for the company’s products or its access to global credit and equity markets; dependence on certain industries for a significant portion of sales; operating difficulties at production sites and product safety and quality liabilities; the company’s ability to keep pace with technological developments in research and development and continue offering innovative products; competitive pressures that could adversely affect market share, sales and profitability; and market volatility that could impair the company’s ability to pass potential increases in corn and other raw-material costs on to customers, obtain raw materials at prices that maintain or increase profitability, or supply the quantities of products and meet delivery times required by customers.

Other risks include the effects of price fluctuations, supply-chain disruptions, tariffs, taxes and shortages affecting materials used in the company’s sourcing, manufacturing and distribution processes, including raw materials, energy, transportation and logistics; the company’s ability to control costs, manage working capital and meet budgets, including completing planned maintenance and capital projects on schedule and within budget; global climate change and legal, regulatory or market measures intended to address it; the ability to identify and complete acquisitions, divestitures or strategic alliances on favorable terms or realize expected synergies; economic, political and other risks inherent in operating internationally and using foreign currencies; the company’s ability to maintain satisfactory labor relations; its ability to attract, train, retain and motivate employees, including key personnel, and maintain good employee relations; the impact of legal and regulatory proceedings; pandemic-related risks; the effect of potential impairment charges on intangible assets and goodwill; global and regional economic policies and changes to applicable laws and regulations; changes in tax rates or exposure to additional tax liabilities; higher interest rates that could increase borrowing costs; risks affecting the company’s ability to raise funds at reasonable rates and other factors affecting access to the financial resources required for future growth and expansion; risks related to the use of artificial intelligence and other advanced technologies and dependence on third-party technology providers; disruptions, security incidents or failures affecting information systems, processes and sites; risks that could affect the continuation of the company’s dividend policy; and the company’s ability to maintain effective internal control over financial reporting.

Ingredion’s forward-looking statements speak only as of the date of publication. The company undertakes no obligation to update them to reflect facts or circumstances arising after publication as a result of new information, future events or developments, or otherwise. If the company updates or corrects one or more statements, investors and readers should not assume that other updates or corrections will follow.

For a more detailed discussion of these and other risks, readers should refer to the risk factors and other information contained in Ingredion’s annual report on Form 10-K for the year ended Dec. 31, 2025, and subsequent reports on Forms 10-Q and 8-K filed with the Securities and Exchange Commission.

Additional information

This press release is provided for informational purposes only. It does not constitute, and is not part of, an offer, invitation or solicitation of an offer to purchase, acquire, subscribe for, sell or transfer securities, or a solicitation of any vote or approval in any jurisdiction, in connection with the company’s all-cash offer for all of the issued and to-be-issued ordinary share capital of Tate & Lyle or otherwise. No sale, issuance or transfer of Tate & Lyle securities may take place in any jurisdiction in violation of applicable law.

The proposed acquisition will be implemented solely by means of a scheme of arrangement or, if the proposed acquisition is implemented by means of a takeover offer, as that term is defined in the U.K. Companies Act 2006, by means of an offer document containing the full terms and conditions of the proposed acquisition. If the company exercises its right to implement the acquisition by means of a takeover offer, the offer will be made in accordance with applicable U.S. laws and regulations.

Contacts: Investors: Noah Weiss, 773-896-5242. Media: Rick Wion, 708-209-6323.

Notes on net sales to unaffiliated customers

(i) Net of intersegment sales of $22 million and $7 million for the third quarters of 2026 and 2025, respectively, and $66 million and $25 million for the first nine months of 2026 and 2025, respectively.

(ii) Net of intersegment sales of $17 million and $12 million for the third quarters of 2026 and 2025, respectively, and $38 million and $39 million for the first nine months of 2026 and 2025, respectively.

(iii) Net of intersegment sales of $37 million and $25 million for the third quarters of 2026 and 2025, respectively, and $112 million and $85 million for the first nine months of 2026 and 2025, respectively.

(iv) Net of intersegment sales of $6 million and $3 million for the third quarters of 2026 and 2025, respectively, and $18 million and $10 million for the first nine months of 2026 and 2025, respectively.

II. Non-GAAP information

To supplement consolidated financial results prepared in accordance with U.S. GAAP, Ingredion uses historical non-GAAP financial measures that exclude certain items recorded under GAAP, including restructuring costs and costs associated with redefining operating segments, net proceeds from divestitures, impairment charges, the Mexican tax provision and other specific items. The term “adjusted” generally refers to these non-GAAP financial measures.

Management uses non-GAAP measures internally to make strategic decisions, forecast future results and evaluate current performance. By presenting non-GAAP measures, management seeks to provide investors with a clearer and more consistent comparison of the company’s operating results and trends across reporting periods.

The use of non-GAAP measures is intended to supplement, and be used in conjunction with, GAAP results. It provides an additional way to analyze the company’s operations and, together with GAAP results, is intended to improve understanding of the factors and trends affecting the business.

The non-GAAP measures may not reflect certain future charges, costs or gains that are inherently difficult to predict or assess because of uncertainty regarding their timing, effects or significance. Adjusted financial measures generally include non-GAAP adjustments, which reflects management’s greater confidence in its ability to forecast adjusted measures than its ability to forecast GAAP measures.

The non-GAAP measures are supplemental to, and are not intended to replace or be superior to, the corresponding GAAP measures. Because they are not prepared in accordance with GAAP, Ingredion’s non-GAAP information may not be comparable with similarly titled measures reported by other companies. The tables in the company’s financial materials reconcile each non-GAAP measure with the most directly comparable GAAP measure.

Net income and earnings per share totals may not add or may be recalculated because of rounding.

Non-GAAP reconciliation notes

(i) During the three- and nine-month periods ended Sept. 30, 2026, Ingredion recorded pretax acquisition and integration costs of $6 million and $59 million, respectively, primarily related to its proposed acquisition of Tate & Lyle. The amounts included gains of $5 million and losses of $42 million on foreign-exchange hedging instruments related to the acquisition for the three- and nine-month periods ended Sept. 30, 2026, respectively. No such activity occurred during the three- and nine-month periods ended Sept. 30, 2025.

(ii) During the three- and six-month periods ended Sept. 30, 2026, the company recorded pretax impairment charges of $6 million and $39 million, respectively. In the third quarter, the company recorded a charge related to the divestiture of its Vanscoy facility in Canada and an impairment charge on certain equity investments. It also recorded charges related to the closure of its Cabo facility in Brazil during the first half of 2026. During the nine months ended Sept. 30, 2025, the company recorded $6 million of pretax impairment charges related to certain equity investments.

(iii) During the three- and nine-month periods ended Sept. 30, 2026, the company recorded a pretax restructuring gain of $17 million and pretax restructuring charges of $8 million, respectively. The gain recorded during the quarter primarily resulted from the gain on the sale of land in Lane Cove, Australia. During the nine-month period ended Sept. 30, 2026, that gain was fully offset by restructuring costs primarily related to the closure of the company’s Cabo facility in Brazil and the divestiture of its Pakistan operations. During the three- and nine-month periods ended Sept. 30, 2025, the company incurred pretax restructuring costs of $3 million and $7 million, respectively, primarily from dismantling expenses following plant closures.

(iv) During the nine-month period ended Sept. 30, 2026, the company recorded a $44 million pretax net gain related to the sale of its Pakistan operations. No such activity occurred during the same period ended Sept. 30, 2025.

(v) During the three- and nine-month periods ended Sept. 30, 2026, the company recorded pretax charges of $8 million and $25 million, respectively, primarily related to the Argo thermal incident. During the quarter and nine months ended Sept. 30, 2025, the company incurred pretax costs of $2 million and recorded a gross benefit of $9 million, respectively, primarily from insurance recoveries and a favorable judgment related to certain indirect taxes.

(vi) This item represents the tax impact resulting from movement in the Mexican peso against the U.S. dollar and its effect on the remeasurement of the company’s financial statements in Mexico during the period.

(vii) During the three- and nine-month periods ended Sept. 30, 2026, the company recorded tax benefits, including interest income related to certain local incentives in Brazil and the recognition of a deferred tax asset in the United States. These benefits were partly offset by tax effects related to current- and prior-year non-GAAP adjustments and the recapture of U.S. tax benefits from prior years.

During the nine-month period ended Sept. 30, 2026, the company also recorded tax benefits related to the use of previously unused capital losses. These gains were partly offset by changes in the company’s provision related to the permanent reinvestment of foreign earnings and the recognition of tax liabilities related to prior years.

For notes (i) through (v), see notes (i) through (v) in the reconciliation of GAAP net income attributable to Ingredion and GAAP diluted earnings per share with adjusted net income attributable to Ingredion and adjusted diluted earnings per share.

For note (i), see note (i) in the reconciliation of GAAP net income attributable to Ingredion and GAAP diluted earnings per share with adjusted net income attributable to Ingredion and adjusted diluted earnings per share.

For notes (i) through (vii), see notes (i) through (vii) in the reconciliation of GAAP net income attributable to Ingredion and GAAP diluted earnings per share with adjusted net income attributable to Ingredion and adjusted diluted earnings per share.

Source: https://www.globenewswire.com/news-release/2026/11/07/3397984/0/fr/ingredion-incorporated-publie-ses-r%C3%A9sultats-du-troisi%C3%A8me-trimestre-2026.html